Tags RedHill Biopharma

Tag: RedHill Biopharma

RedHill Biopharma

RedHill Biopharma Completes Enrollment for COVID-19 U.S. Phase 2 Study with Opaganib

RedHill Biopharma Ltd (Nasdaq: RDHL), a specialty biopharmaceutical company, today announced that the U.S. Phase 2 study with opaganib (Yeliva®, ABC294640) in patients hospitalized...